Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grabowski

Showing results (221-230 of 259) with videos related to

Pageof 26
Sort By:
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
European Journal of Pediatrics|December 17, 2003
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statementsGregory A Grabowski, Generoso Andria, Antonio Baldellou, et al.
European Journal of Pediatrics|December 17, 2003
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoringAntonio Baldellou, Generoso Andria, Pauline E Campbell, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|December 18, 2009
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouseYing Sun, Huimin Ran, Matt Zamzow, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1Gregory A Grabowski, Katherine Kacena, J Alexander Cole, et al.
ACS Applied Polymer Materials|October 9, 2024
Effect of Molecular Weight and Layer Thickness on the Dielectric Breakdown Strength of Neat and Homopolymer Swollen Lamellar Block Copolymer FilmsSaumil Samant, Monali Basutkar, Maninderjeet Singh, et al.
Annals of Internal Medicine|January 1, 1995
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sourcesG A Grabowski, N W Barton, G Pastores, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Human Molecular Genetics|May 16, 2008
Neurological deficits and glycosphingolipid accumulation in saposin B deficient miceYing Sun, David P Witte, Huimin Ran, et al.
Pageof 26

Showing results (221-230 of 259) with videos related to

Sort By:
Pageof 26
Plos One|May 3, 2011
Isofagomine in vivo effects in a neuronopathic Gaucher disease mouseYing Sun, Huimin Ran, Benjamin Liou, et al.
European Journal of Pediatrics|December 17, 2003
Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statementsGregory A Grabowski, Generoso Andria, Antonio Baldellou, et al.
European Journal of Pediatrics|December 17, 2003
Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoringAntonio Baldellou, Generoso Andria, Pauline E Campbell, et al.
Human Molecular Genetics|August 5, 2024
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher diseaseYi Lin, Xiangli Zhao, Benjamin Liou, et al.
Human Molecular Genetics|December 18, 2009
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouseYing Sun, Huimin Ran, Matt Zamzow, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 7, 2009
Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1Gregory A Grabowski, Katherine Kacena, J Alexander Cole, et al.
ACS Applied Polymer Materials|October 9, 2024
Effect of Molecular Weight and Layer Thickness on the Dielectric Breakdown Strength of Neat and Homopolymer Swollen Lamellar Block Copolymer FilmsSaumil Samant, Monali Basutkar, Maninderjeet Singh, et al.
Annals of Internal Medicine|January 1, 1995
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sourcesG A Grabowski, N W Barton, G Pastores, et al.
Human Molecular Genetics|March 7, 2014
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease miceYou-hai Xu, Kui Xu, Ying Sun, et al.
Human Molecular Genetics|May 16, 2008
Neurological deficits and glycosphingolipid accumulation in saposin B deficient miceYing Sun, David P Witte, Huimin Ran, et al.
Pageof 26